Peer-reviewed research on the peptides we formulate. Not medical advice — just the science.
A review of preclinical and translational research on BPC-157 across tendon, ligament, muscle, and osteotendinous junction repair models — with attention to growth-factor pathways and the local-action profile that distinguishes it from systemic compounds.
A foundational review of the β-thymosin family, including the actin-sequestering 43-amino-acid parent protein from which TB-500 is derived. Covers cellular distribution, biological activities, and the regenerative-medicine context.
A randomised, double-blind, placebo- and active-controlled phase 2 trial of retatrutide — the GLP-1/GIP/glucagon triple-agonist — in type 2 diabetes. Reports glycemic and weight-reduction outcomes across multiple dose tiers.
Systematic review and meta-analysis of tirzepatide trials in type 2 diabetes. Synthesises efficacy and safety across the dual GLP-1 / GIP receptor agonism profile that defines the compound.
A review of GHK-Cu as a multi-pathway modulator in dermal regeneration — collagen synthesis, antioxidant activity, copper transport, and gene-regulatory effects observed across cell and animal studies.
A review of α-MSH derived peptides — including KPV — and their anti-inflammatory effects beyond the canonical melanocortin pharmacophore. Provides the mechanistic basis for KPV use in inflammation-driven skin conditions.